TNF and Crohn disease: Adalimumab was used to treat this patient as an alternative choice without relapse of hemolysis.<h4>Clinical discussion</h4>Drug induced Hemolysis is not a well-known complication post receiving Tumor necrosis factor Inhibitor (TNF) -α infusion in patients with Crohn's disease.